These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35073227)

  • 41. Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island.
    Zang X; Macmadu A; Krieger MS; Behrends CN; Green TC; Morgan JR; Murphy SM; Nolen S; Walley AY; Schackman BR; Marshall BD
    Int J Drug Policy; 2021 Dec; 98():103435. PubMed ID: 34482264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disparities in opioid overdose survival and naloxone administration in Pennsylvania.
    Holmes LM; Rishworth A; King BH
    Drug Alcohol Depend; 2022 Sep; 238():109555. PubMed ID: 35810621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The need for multiple naloxone administrations for opioid overdose reversals: A review of the literature.
    Abdelal R; Banerjee AR; Carlberg-Racich S; Darwaza N; Ito D; Epstein J
    Subst Abus; 2022; 43(1):774-784. PubMed ID: 35112993
    [No Abstract]   [Full Text] [Related]  

  • 44. One year mortality of patients treated with naloxone for opioid overdose by emergency medical services.
    Weiner SG; Baker O; Bernson D; Schuur JD
    Subst Abus; 2022; 43(1):99-103. PubMed ID: 32242763
    [No Abstract]   [Full Text] [Related]  

  • 45. Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose?
    Marino R; Landau A; Lynch M; Callaway C; Suffoletto B
    Addiction; 2019 Sep; 114(9):1575-1581. PubMed ID: 31013394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Best Practices for a Novel EMS-Based Naloxone Leave behind Program.
    Scharf BM; Sabat DJ; Brothers JM; Margolis AM; Levy MJ
    Prehosp Emerg Care; 2021; 25(3):418-426. PubMed ID: 32420791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. At-a-glance - What can paramedic data tell us about the opioid crisis in Canada?
    Do MT; Furlong G; Rietschlin M; Leyenaar M; Nolan M; Poirier P; Field B; Thompson W
    Health Promot Chronic Dis Prev Can; 2018 Sep; 38(9):339-342. PubMed ID: 30226728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Naloxone Use Among Emergency Department Patients with Opioid Overdose.
    Marco CA; Trautman W; Cook A; Mann D; Rasp J; Perkins O; Ballester M
    J Emerg Med; 2018 Jul; 55(1):64-70. PubMed ID: 29776702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overdoses due to fentanyl and its analogues (F/FAs) push naloxone to the limit.
    Pergolizzi JV; Dahan A; Ann LeQuang J; Raffa RB
    J Clin Pharm Ther; 2021 Dec; 46(6):1501-1504. PubMed ID: 34111307
    [TBL] [Abstract][Full Text] [Related]  

  • 50. "They're not doing enough.": women's experiences with opioids and naloxone in Toronto.
    Macleod ER; Tajbakhsh I; Hamilton-Wright S; Laliberte N; Wiese JL; Matheson FI
    Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):26. PubMed ID: 33743756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.
    Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N
    Emerg Med Australas; 2022 Aug; 34(4):509-518. PubMed ID: 35021268
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis.
    Walley AY; Xuan Z; Hackman HH; Quinn E; Doe-Simkins M; Sorensen-Alawad A; Ruiz S; Ozonoff A
    BMJ; 2013 Jan; 346():f174. PubMed ID: 23372174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EMS naloxone administration as non-fatal opioid overdose surveillance: 6-year outcomes in Marion County, Indiana.
    Ray BR; Lowder EM; Kivisto AJ; Phalen P; Gil H
    Addiction; 2018 Dec; 113(12):2271-2279. PubMed ID: 30255531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments.
    Miner NB; Schutzer WE; Zarnegarnia Y; Janowsky A; Torralva R
    Drug Alcohol Depend; 2021 Oct; 227():108974. PubMed ID: 34492557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of Opioid Overdose Risk Factors and Naloxone Prescribing in US Adults.
    Lin LA; Brummett CM; Waljee JF; Englesbe MJ; Gunaseelan V; Bohnert ASB
    J Gen Intern Med; 2020 Feb; 35(2):420-427. PubMed ID: 31820218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statewide Policy to Increase Provision of Take-Home Naloxone at Emergency Department Visits for Opioid Overdose, Rhode Island, 2018‒2019.
    Griffith J; Yorlets RR; Chambers LC; Davis CS; Wentz A; Beaudoin FL; Baird J; Samuels EA
    Am J Public Health; 2023 Apr; 113(4):372-377. PubMed ID: 36745856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reducing the stigma surrounding opioid use disorder: evaluating an opioid overdose prevention training program applied to a diverse population.
    Bascou NA; Haslund-Gourley B; Amber-Monta K; Samson K; Goss N; Meredith D; Friedman A; Needleman A; Kumar VK; Fischer BD
    Harm Reduct J; 2022 Jan; 19(1):5. PubMed ID: 35034649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Naloxone interventions in opioid overdoses: a systematic review protocol.
    Shaw LV; Moe J; Purssell R; Buxton JA; Godwin J; Doyle-Waters MM; Brasher PMA; Hau JP; Curran J; Hohl CM
    Syst Rev; 2019 Jun; 8(1):138. PubMed ID: 31186071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opioid crisis at the Jersey Shore-special report.
    Dudley LS; Konomos D; Robbins V; Qiu L; Bauter R; Merlin MA
    J Public Health (Oxf); 2018 Jun; 40(2):e112-e117. PubMed ID: 28977468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Community-based opioid overdose prevention programs providing naloxone - United States, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(6):101-5. PubMed ID: 22337174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.